atezolizumab,bevacizumab
roche
['gyn', 'bevacizumab', 'atalante', 'ovarian', 'atezo']
#esmo22 gyn cancers. atalante: no benefit of atezolizumab vs pbo in non-mucinous epithelial ovarian, fallopian tube, peritoneal cancer treated with chemotherapy and bevacizumab #gynsm 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge